US2016130560A1PendingUtilityA1
Methods for in vitro maturation of ovarian follicles
Est. expiryJan 17, 2028(~1.5 yrs left)· nominal 20-yr term from priority
Inventors:Kui Liu
A61P 43/00C12N 5/0682G01N 33/502A61B 17/435C12N 15/8776A61P 15/08C12Q 1/42C12N 5/0609A61B 17/43C12N 2501/73A61P 15/00
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to methods to be used in the maturation of ovarian follicles and oocytes. More specifically, the invention concerns the use of inhibitors of the phosphatase PTEN, such as oxovanadate and peroxovanadate complexes, in methods for in vitro and in vivo maturation of follicles and oocytes.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method for the in vitro activation of mammalian non-growing follicles, the method comprising the step of incubating the mammalian follicles in a physiological acceptable medium comprising one or more inhibitors of PTEN.
3 . The method according to claim 2 , wherein the non-growing follicles, are selected from primordial, intermediate and primary follicles.
4 . The method according to claim 2 , wherein the activated follicles are further used for in vitro fertilization.
5 . The method according to claim 2 , wherein the non-growing follicles are human.
6 . The method according to claim 2 wherein the inhibitor of PTEN is selected from;
Bisperoxo(bipyridine)oxovanadate,
Bisperoxo(1,10-phenanthroline)oxovanadate,
Bisperoxo(picolinato)oxovanadate,
Bisperoxo(5-hydroxypyridine-2-carboxyl)oxovanadate,
Di-(picolinate) oxovanadate,
Di-(3-hydroxypicolinate) oxovanadate,
Bisperoxo(phenylbiguanide)oxovanadate,
Di-(phenylbiguanide)oxovanadate, or
Bisperoxo(isoquinolinecarboxylic acid)oxovanadate.
7 . A method for the in vitro maturation of an oocyte which comprises the activation of non-growing follicles according to claim 2 .
8 . A method of in vitro fertilization comprising implanting an embryo, wherein said embryo is produced by a method comprising treating a mature oocyte with sperm, wherein said oocyte is produced by the method of claim 7 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.